Agreement includes global patent cross license of cellular technologies, including 5G Settlement ends all ongoing patent related legal disputes between the parties In the second quarter 2021, IPR licensing revenues are expected to be SEK 2.0 b. to 2.5 b. … Read the full press release
Posted in Business, Industrial, International Trade, Internet & Online, Management, News, Sweden, Technology, Telecom
Tagged cellular technologies, Christina Petersson, cross-license agreement, Ericsson, FRAND, handsets, IPR, lawsuits, mobile industry, network infrastructure, open standardization, patent licenses, Patents, Samsung, United States International Trade Commission, USITC
18-7-2013 — /europawire.eu/ — Reliable identification of tires with embedded RFID1 technology already has shown how it can improve tire tracking throughout its life cycle. Michelin group has been an internationally recognized leader for creating and fostering harmonized international standards for Tire RFID1. … Read the full press release
Brussels, 6-5-2013 — /europawire.eu/ — The European Commission has informed Motorola Mobility of its preliminary view that the company’s seeking and enforcing of an injunction against Apple in Germany on the basis of its mobile phone standard-essential patents (“SEPs”) amounts to an abuse … Read the full press release
Posted in Belgium, Business, European Union, Germany, Government, Internet & Online, Law, Technology, Telecom
Tagged ANTITRUST, Apple, Competition, court, dominant position, ETSI, EU antitrust rules, FRAND, FRAND royalties, GPRS, GSM, GSM standard, INNOVATION, intellectual property, intellectual property rights, Joaquin Almunia, licence, licensee, Motorola Mobility, patent infringements, patent licensees, Patents, SEPs, wireless communications
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
